Enveric Biosciences Inc.

NASDAQ: ENVB · Real-Time Price · USD
1.08
-0.03 (-2.70%)
At close: Aug 15, 2025, 3:57 PM
1.09
0.98%
After-hours: Aug 15, 2025, 07:16 PM EDT

Enveric Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a 647.09K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a 82.49K n/a 84.78K 85.41K 84.68K 95.84K 114.37K 113.33K 90.42K 121.1K 85.5K 103.72K 197.26K 173.7K 174.02K 136.64K
Gross Profit
n/a n/a n/a -84.78K -85.41K 562.41K -95.84K -114.37K -113.33K -90.42K -121.1K -85.5K -103.72K -197.26K -173.7K -174.02K -136.64K
Operating Income
-2.19M -3.17M -2.08M -1.9M -2.48M -2.38M -3.45M -5.76M -4.86M -12.26M -5.66M -4.71M -4.8M -50.98M -3.52M -3.36M -6.76M
Interest Income
n/a n/a n/a n/a n/a 566.00 2.24K 916.00 0.01 0.14 0.31 n/a n/a n/a n/a n/a n/a
Pretax Income
-2.18M -3.15M -2.08M -1.88M -2.46M -3.41M -2.82M -6.36M -4.68M -10.16M -2.48M -2.79M -4.52M -49.56M -2.71M -908.29K -3.25M
Net Income
-2.18M -3.15M -2.08M -1.88M -2.46M -3.44M -2.82M -6.36M -4.62M -14.05M 686.73K -881.39K -4.25M -42.11M -2.71M -908.29K -3.25M
Selling & General & Admin
1.36M 1.99M 1.24M 1.3M 1.93M 930.68K 2.01M 3.16M 2.78M 2.82M 3.51M 2.5M 2.77M 9.63M 2.12M 2.31M 6.61M
Research & Development
746.37K 1.1M 762.72K 515.5K 458.15K 1.37M 1.35M 2.51M 1.99M 1.89M 2.06M 2.12M 1.96M 2.49M 1.22M 879.84K 157.95K
Other Expenses
81.02K n/a 84.81K 84.78K n/a n/a 86.3K 86.52K 86.49K 86.5K 86.65K 85.5K 69.27K -826.58K 173.7K 174.02K -298.71K
Operating Expenses
2.19M 3.09M 2.08M 1.9M 2.39M 2.3M 3.45M 5.76M 4.86M 4.8M 5.66M 4.71M 4.8M 12.3M 3.52M 3.36M 6.76M
Interest Expense
n/a n/a n/a n/a 696.00 n/a 2.24K n/a 11.00 135.00 308.00 668.00 4.14K 5.13K 370.00 4.82K n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a -1.85M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
n/a 3.17M 2.08M 1.9M 2.48M 2.38M 3.45M 5.76M 4.86M 4.8M 5.66M 4.71M 4.8M 12.3M 3.52M 3.36M 6.76M
Income Tax Expense
n/a 7.2K n/a n/a 1.73K 22.32K -6.59K n/a -59.82K 3.89M -3.17M -1.91M -275.97K 28.97M n/a n/a n/a
Shares Outstanding (Basic)
1.8K 502.9K 580.2K 2.29M 4M 2.53M 2.53M 2.53M 2.53M 2.53M 2.53M 1.05M 847.13K 462.86K 459.29K 426.67K 324.41K
Shares Outstanding (Diluted)
1.8K 654.92K 1.41M 1.41M 1.41M 2.35M 2.16M 2.11M 2.08M 2.08M 1.79M 1.05M 847.13K 462.86K 459.29K 426.88K 324.41K
EPS (Basic)
-1.22K -5.82 -3.59 -0.82 -0.61 -1.46 -1.3 -3.02 -2.22 -6.76 0.27 -0.84 -5.01 -90.97 -5.91 -2.13 -10.02
EPS (Diluted)
-1.22K -2.37 -1.48 -1.34 -1.75 -1.46 -1.3 -3.02 -2.22 -6.76 0.38 -0.84 -5.01 -90.97 -5.91 -2.13 -10.02
EBITDA
-2.11M -3.09M -2M -1.81M -2.39M -4.2M -3.36M -5.67M -4.77M -10.07M -5.57M -2.7M -4.42M -49.36M -3.34M -729.45K -3.11M
EBIT
-2.19M -3.17M -2.08M -1.9M -2.48M -3.41M -3.45M -5.76M -4.86M -10.16M -5.66M -2.79M -4.52M -49.56M -2.71M -903.47K -3.25M
Depreciation & Amortization
81.02K 82.49K 84.81K 84.78K 85.41K 84.68K 95.84K 114.37K 113.33K 90.42K 121.1K 85.5K 103.72K 197.26K 173.7K 174.02K 136.64K